Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Anna Brujats, Càndid Villanueva

Clin Mol Hepatol. 2024;30(4):1055-1059. Published online March 6, 2024

DOI: https://doi.org/10.3350/cmh.2024.0144

View: 6344 Download: 75

Chuan Liu, Ling Yang, Hong You, Gao-Jun Teng, Xiaolong Qi

Received August 27, 2024 Accepted August 29, 2024

DOI: https://doi.org/10.3350/cmh.2024.0723 [Accepted]

View: 655 Download: 30

Haiyu Wang, Jinjun Chen

Received March 9, 2025 Accepted March 15, 2025

DOI: https://doi.org/10.3350/cmh.2025.0274 [Accepted]

View: 140 Download: 4

Do Seon Song

Received March 13, 2025 Accepted March 20, 2025

DOI: https://doi.org/10.3350/cmh.2025.0296 [Accepted]

View: 51 Download: 2

1 |

Viewed By 7362	MAFLD: How is it different from NAFLD?
Viewed By 6913	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5569	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5338	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4765	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 270	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 186	MAFLD: How is it different from NAFLD?
Cited By 93	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search